Therapeutics | Yale Ventures

Therapeutics

Janghoo

Innovative approach to treat ALS using a novel small molecule target

Small molecule and enzymatic approaches to revert aberrant phase transitions in neurological disorders

Alfred

Advancing a non-hallucinogenic psychedelic drug combination

Petragen

VST-Bio

Alphina

RigImmune

Statera

Freedom Bio

Pangolin

Subscribe to Therapeutics